Skip to main content
VCbacked
Log inGet Started

ViAqua Therapeutics

Misgav, Israel

ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.

$8.3M raised
Sep 2023
Venture - Series Unknown
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

S2G InvestmentsIsrael Innovation AuthorityClay CapitalTechnion - Israel Institute of TechnologyRabo Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ViAqua Therapeutics

How much funding has ViAqua Therapeutics raised?
ViAqua Therapeutics has raised $8.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Who are ViAqua Therapeutics's investors?
ViAqua Therapeutics's investors include S2G Investments, Israel Innovation Authority, Clay Capital, Technion - Israel Institute of Technology, Rabo Ventures.
Where is ViAqua Therapeutics headquartered?
ViAqua Therapeutics is headquartered in Misgav, Israel.
What does ViAqua Therapeutics do?
ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.
What stage is ViAqua Therapeutics at?
ViAqua Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ViAqua Therapeutics — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/viaqua-therapeutics. Accessed June 5, 2026.
APA
VCBacked. (2023). ViAqua Therapeutics — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/viaqua-therapeutics
Wikipedia (cite web)
{{cite web |title=ViAqua Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/viaqua-therapeutics |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong